<DOC>
	<DOCNO>NCT00145886</DOCNO>
	<brief_summary>The purpose study determine treatment new medication , recombinant human parathyroid hormone ( rhPTH ) affect calcium balance bone strength .</brief_summary>
	<brief_title>rhPTH Therapy Low Turnover Bone Fragility</brief_title>
	<detailed_description>Subjects bone biopsy definitively determine low bone turnover . Subjects treat doctor decide treatment rhPTH ( recombinant human parathyroid hormone ) optimal admission study . During study , subject several test clarify rhPTH affect calcium metabolism bone property . All study perform University Chicago General Clinical Research Center ( GCRC ) . To examine effect PTH ( parathyroid hormone ) calcium metabolism , subject admit GCRC 3 day begin study . Subjects plastic needle insert vein enable nurse draw blood repeatedly without stick every time . Subjects 120 mL ( 8 tablespoon ) blood drawn 3 day period . Subjects allow choose food regular hospital menu amount calcium diet day spend GCRC . The first day use observe calcium balance without medication subsequent 2 day use determine calcium balance change response medication rhPTH . Subjects take medication morning , breakfast - consider time 0 . During 3 day , blood take 0 , 2 , 4 , 6 , 8 , 12 , 16 , 20 hour examination serum calcium 0 , 4 12 hour measurement PTH ( produce body ) . On first 3rd day urine collect measure much calcium lose urine . After Subjects receive medication 3 month admit GCRC , time 2 day continue take medication measurement last 2 day first admission . The admission repeat 12 month treatment . During admission , 80 mL ( 5 ½ tablespoon ) blood drawn . In addition 3 inpatient stay CRC , subject also several test outpatient . The test use evaluate effect rhPTH bone . To end , 3 type test . 1 . To evaluate bone turnover ( activity bone cell ) subject blood urine collect measurement biochemical marker bone turnover ( chemical blood urine reflect activity bone cell ) measure 1 , 2 , 3 , 6 , 9 , 12 month . Subjects 10 mL ( 2 teaspoon ) blood drawn visit . 2 . To evaluate change bone density subject bone density test lumbar spine , hip , heel wrist measure every 3 month 12 month . 3 . To evaluate change architecture structure bone subject 2 test . First , heel image obtain bone density test ( # 2 ) subject radiographic texture analysis . This method computerized analysis pattern bone radiographic image suppose differentiate strong weak bone base difference radiographic texture . The second test bone biopsy . A bone biopsy involve insert needle skin directly bone obtain piece bone 1 cm ( less ½ inch ) length 0.3 cm ( 1/10 inch ) diameter . Before biopsy needle insert numbing medication inject prevent pain procedure . You also receive medication vein almost asleep procedure ( intravenous sedation ) . Most people experience minor pain day biopsy . Subjects first bone biopsy enrol study . A second bone biopsy perform 12 month treatment rhPTH .</detailed_description>
	<mesh_term>Osteopetrosis</mesh_term>
	<criteria>: patient history increase bone fragility BMD criterion ( T score &gt; 1 ) . In addition , subject enrol clear evidence low bone turnover indicate low normal level biochemical marker bone turnover find low bone turnover bone biopsy . Each subject his/her treat physician agree rhPTH best treatment patient . Treatment rhPTH consider bone histomorphometry reveals low turnover state excludes know form bone disease osteomalacia . Subjects pregnant young 20 exclude . Subjects osteoporosis</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>low bone turnover ; sclerosing bone disorder ,</keyword>
	<keyword>osteopetrosis</keyword>
</DOC>